A bolder valuation, backed by a credible growth story

A residential health care operator was preparing for a capital raise to accelerate its growth. The board believed an independent net asset valuation had undervalued the business relative to public market and recent transaction benchmarks, and wanted a validated view of enterprise value, overhead efficiency and growth options before going to investors.

Management needed confidence in the full set of investment options, and clarity on succession planning and the case for an institutional investor vehicle. Without a credible, well-evidenced equity story, the raise risked leaving value on the table.

We developed a valuation model built on a multi-year Group cashflow, using a sum-of-the-parts approach alongside per-room and EBITDA industry benchmark comparisons, to give a robust view of enterprise value.

We then sized and ranked every growth lever by return, spanning acquisitions and greenfield and brownfield residential health care facilities. We benchmarked overheads and valuation against listed peers, identified initiatives to sharpen the cost base, and approached acquisition targets and investors directly to test appetite and refine the value proposition for each.